Articles:

Grouse JR, 3rd, MC Allan, and MB Elam

Clinical manifestation of atherosclerotic peripheral arterial disease and the role of cilostazol in treatment of intermittent claudication
J Clin Pharmacol 2002 42: 1291. [Abstract] [PDF]  

SN Nowak, DJ Edwards, A Clarke, GD Anderson, and LA Jaber

Pioglitazone: effect on CYP3A4 activity
J Clin Pharmacol 2002 42: 1299. [Abstract] [PDF]  

JM Jansat, J Costa, P Salva, FJ Fernandez, and A Martinez-Tobed

Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers
J Clin Pharmacol 2002 42: 1303. [Abstract] [PDF]  

TC Marbury, RA Blum, C Rauch, and JL Pinquier

Pharmacokinetics and safety of a single oral dose of once-daily alfuzosin, 10 mg, in male subjects with mild to severe renal impairment
J Clin Pharmacol 2002 42: 1311. [Abstract] [PDF]  

B Tammara, JM Trang, M Kitani, G Miyamoto, and SL Bramer

The pharmacokinetics of toborinone in subjects with congestive heart failure and concomitant renal impairment and/or concomitant hepatic impairment
J Clin Pharmacol 2002 42: 1318. [Abstract] [PDF]  

MJ Fossler, WF Ebling, S Ma, D Kornhauser, J Mondick, JS Barrett, D Garner, CY Quon, and Pieniaszek HJ, Jr

Integrated pharmacokinetic/pharmacodynamic model of XV459, a potent and specific GPIIb/IIIa inhibitor, in healthy male volunteers
J Clin Pharmacol 2002 42: 1326. [Abstract] [PDF]  

N Yasui-Furukori, T Kondo, T Takahata, K Mihara, S Ono, S Kaneko, and T Tateishi

Effect of dietary fat content in meals on pharmacokinetics of quazepam
J Clin Pharmacol 2002 42: 1335. [Abstract] [PDF]  

F Huang, KC Lasseter, L Janssens, T Verhaeghe, H Lau, and Q Zhao

Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together
J Clin Pharmacol 2002 42: 1341. [Abstract] [PDF]  

PD Martin, J Kemp, AL Dane, MJ Warwick, and DW Schneck

No effect of rosuvastatin on the pharmacokinetics of digoxin in healthy volunteers
J Clin Pharmacol 2002 42: 1352. [Abstract] [PDF]  

DM Anderson, S Shelley, N Crick, and M Buraglio

No effect of the novel antidiabetic agent nateglinide on the pharmacokinetics and anticoagulant properties of warfarin in healthy volunteers
J Clin Pharmacol 2002 42: 1358. [Abstract] [PDF]  

S Rasty, S Borzak, and JE Tisdale

Bleeding associated with eptifibatide targeting higher risk patients with acute coronary syndromes: incidence and multivariate risk factors
J Clin Pharmacol 2002 42: 1366. [Abstract] [PDF]  

E Uejima, K Takahashi, T Morisaki, K Takahashi, M Ohno, Y Nishida, M Moriya, M Kaido, K Abe, S Sakoda, T Yanagihara, N Kurokawa, and J Azuma

Microsomal enzyme induction and clinical aggravation of porphyria: the evaluation of human urinary 6beta-hydroxycortisol/cortisol ratio as the index of hepatic CYP3A4 activity
J Clin Pharmacol 2002 42: 1374. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.